Twice single-use? MHRA issues draft guidance for device makers

By Dan Stanton

- Last updated on GMT

The new guidance proposes the packaging for re-manufactured single-use devices smust include the above symbol
The new guidance proposes the packaging for re-manufactured single-use devices smust include the above symbol

Related tags European union

Companies that recommission old single-use devices would have the same liability as the original device maker under draft guidelines proposed by the MHRA.

As their name implies, single-use devices (SUDs) are made for a one-time application but according to the UK’s regulatory authority MHRA, some companies – ‘re-manufacturers’ – are decontaminating, cleaning and sterilising  such products and placing them back on the market.

As such, the agency has called upon healthcare professionals, manufacturers and providers of medical devices to comment on new guidance which would help ensure the safety of re-manufactured devices.

“Anyone who re-manufactures a single-use device has the same legal responsibility for it as the original manufacturer,”​ the guidelines state.

Furthermore, while SUDs can be re-manufactured in the UK, a company must meet all relevant criteria under the appropriate Medical Devices Directive, place a CE-mark on their product, and add a symbol – the figure ‘2’ in a circle with a line through it – on the packaging .

“There is currently no UK guidance related to re-manufacturing of single-use,” ​MHRA spokesman Nick Spears told this publication, adding that guidance is already available in a number of other EU countries, the US and Australia on this issue.

“The guidance is proposing a UK position on re-manufacturing of single-use devices, thus the target audience for is primarily UK Notified Bodies, and manufacturers who put their products on the UK market.”

One point the guidelines makes clear is that there is a difference between re-manufacturing and re-processing, the former being done by a company – usually the original device manufacturer – that must demonstrate validity and surety of all the manufacturing processes.

Reprocessing SUDs is where a person or organisation, cleans and sterilises the medical device and it goes back into the healthcare environment -  contrary to the manufacturer’s instructions, and with all the markings of the original device – and is not advised by the MHRA.

Related news

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Follow us

Products

View more

Webinars